Papa Bear Wednesday, 05/11/16 12:07:23 AM Re: None Post # of 67 LGNDZ: Ligand has assembled one of the largest and most diverse portfolios in the biotech and pharmaceutical industry. Our partners and licensees fund the development and commercialization of our portfolio and we are entitled to receive royalties and milestones on program success. Currently approved portfolio drugs include those that treat cancer, osteoporosis, fungal infections and low blood platelets, among others. Our partners and licensees have programs currently in clinical development targeting seizure, coma, cancer, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others. www.ligand.com/portfolio-summary/overview Please check out my brand new board! It is called The Bear Den and it is right here: investorshub.advfn.com/The-Bear-Den-30641/ Making Money and Making Friends everyday!